Skip to main content
Top
Published in: Rheumatology International 1/2012

01-01-2012 | Original Article

Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience

Authors: Fan Lian, Yu Wang, Xiuyan Yang, Hanshi Xu, Liuqin Liang

Published in: Rheumatology International | Issue 1/2012

Login to get access

Abstract

Hyperferritinemia has been reported in adult-onset Still’s disease (AOSD). This study aims to investigate clinical features of AOSD in Chinese population and diagnostic value of different hyperferritinemia cutoff points based on ROC curve. A total of 48 patients from October 2002 to February 2007 diagnosed AOSD in the department of rheumatology, the first affiliated hospital of Sun Yat-set University were enrolled. A total of 86 patients mainly complaining fever >39°C for over one week and meeting Yamaguchi criteria but confirmed as non-AOSD by other serological or pathological tests were obtained from the same department as controls. Total serum ferritin levels were determined at the time of admission. Clinical features of AOSD in Chinese population were similar to previous studies. Significantly higher levels of total serum ferritin were presented in patients with AOSD (8100.7 ± 13678.5) compared with non-AOSD controls (448.3 ± 539.4) (P < 0.01). No differences were found in serum ferritin level between different categories of non-AOSD patients (P > 0.05). High value of area under receiver operating characteristic curve (ROC curve) suggested that ferritin was very predictive in AOSD diagnosis. Three cutoff points were picked based on clinical practice and ROC curve. Ferritin level ≥2,500 µg/L appeared to be highly specific for a diagnosis of AOSD, yet the low sensitivity may falsely ruled out patients with true AOSD. Hyperferritinemia ≥750 µg/L was seldom observed in inflammatory diseases or solid tumor. Hyperferritinemia ≥1,250 µg/L could mostly rule out other autoimmune diseases and hematologic diseases. Combined Yamaguchi criteria and hyperferritinemia gave better prediction for AOSD. In conclusion, different hyperferritinemia cutoff points observed in ROC curve help to optimize diagnostic and therapeutic strategy.
Literature
1.
go back to reference Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD (1992) Adult onset still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 51:529–532PubMed Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD (1992) Adult onset still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 51:529–532PubMed
2.
go back to reference Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H et al (2003) Fever of unknown origin: a review of 20 patients with adult-onset still’s disease. Clin Rheumatol 22:89–93PubMed Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H et al (2003) Fever of unknown origin: a review of 20 patients with adult-onset still’s disease. Clin Rheumatol 22:89–93PubMed
3.
go back to reference Crispin JC, Martinez-Banos D, Alcocer-Varela J (2005) Adult-onset still disease as the cause of fever of unknown origin. Medicine (Baltimore) 84:331–337 Crispin JC, Martinez-Banos D, Alcocer-Varela J (2005) Adult-onset still disease as the cause of fever of unknown origin. Medicine (Baltimore) 84:331–337
4.
go back to reference Owlia MB (2006) Clinical spectrum of connective tissue disorders. J Indian Acad Community Med 7:217–224 Owlia MB (2006) Clinical spectrum of connective tissue disorders. J Indian Acad Community Med 7:217–224
5.
go back to reference Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L et al (1996) Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 23:495–497PubMed Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L et al (1996) Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 23:495–497PubMed
6.
go back to reference Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136 Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136
7.
go back to reference Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M (1987) Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 14:1139–1146PubMed Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M (1987) Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 14:1139–1146PubMed
8.
go back to reference Motoo Y, Ohta H, Okai T, Sawabu N (1991) Adult-onset still’s disease: hepatic involvement and various serum markers relating to the disease activity. Jpn J Med 30:247–250PubMed Motoo Y, Ohta H, Okai T, Sawabu N (1991) Adult-onset still’s disease: hepatic involvement and various serum markers relating to the disease activity. Jpn J Med 30:247–250PubMed
9.
go back to reference Meijvis SC, Endeman H, Geers AB, ter Borg EJ (2007) Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med 65:212–214PubMed Meijvis SC, Endeman H, Geers AB, ter Borg EJ (2007) Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med 65:212–214PubMed
10.
go back to reference Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M et al (2009) Adult-onset still’s disease. Int J Clin Pract 63(7):1050–1055 Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M et al (2009) Adult-onset still’s disease. Int J Clin Pract 63(7):1050–1055
11.
go back to reference Kelly J, Chowienczyk P, Gibson T (2001) Sore throat and hyperferritinemiaaemia. J R Soc Med 94:400–401PubMed Kelly J, Chowienczyk P, Gibson T (2001) Sore throat and hyperferritinemiaaemia. J R Soc Med 94:400–401PubMed
12.
go back to reference Ten Kate J, Drenth JP, Kahn MF, van Deursen C (2001) Iron saturation of serum ferritin in patients with adult onset still’s disease. J Rheumatol 28:2213–2215PubMed Ten Kate J, Drenth JP, Kahn MF, van Deursen C (2001) Iron saturation of serum ferritin in patients with adult onset still’s disease. J Rheumatol 28:2213–2215PubMed
13.
go back to reference Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset still’s disease. J Rheumatol 28:322–329PubMed Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset still’s disease. J Rheumatol 28:322–329PubMed
14.
go back to reference Viges S, Le Moel G, Fautrel B et al (2001) Percentage of glycosylated serum ferritin remains low throughout the course of adult onset still’s disease. Ann Rheu Dis 59:347–350 Viges S, Le Moel G, Fautrel B et al (2001) Percentage of glycosylated serum ferritin remains low throughout the course of adult onset still’s disease. Ann Rheu Dis 59:347–350
15.
go back to reference Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult still’s disease. J Rheumatol 19:424–430PubMed
16.
go back to reference Van Reeth C, Le Moel G, Lasne Y, Revenant MC, Agneray J, Kahn MF et al (1994) Serum ferritin and isoferritins are tools for diagnosis of active adult still’s disease. J Rheumatol 21:890–895PubMed Van Reeth C, Le Moel G, Lasne Y, Revenant MC, Agneray J, Kahn MF et al (1994) Serum ferritin and isoferritins are tools for diagnosis of active adult still’s disease. J Rheumatol 21:890–895PubMed
Metadata
Title
Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience
Authors
Fan Lian
Yu Wang
Xiuyan Yang
Hanshi Xu
Liuqin Liang
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1601-4

Other articles of this Issue 1/2012

Rheumatology International 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.